Innospec Quarterly Cash Flow Statement
NASDAQ: IOSPIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innospec free cash flow
In the quarter ended Jun 30, 2026, Innospec generated $7.2 million of operating cash flow and spent $17.7 million on capital expenditures. That left free cash flow of -$10.5 million, a free-cash-flow margin of -2.1% of revenue. Innospec returned $6.4 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
Innospec cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 31.20M | 30.80M | 47.40M | 12.90M | 23.90M | 33.60M | -70.40M | 33.40M | 31.20M | 41.40M | 37.80M | 39.20M |
| Net Income growth (YoY) | +30.54% | -8.33% | — | -61.38% | -23.40% | -18.84% | -286.24% | -14.80% | +7.96% | +24.70% | +48.24% | +1.29% |
| Depreciation & Amortization | 10.00M | 9.90M | 9.40M | 12.20M | 11.10M | 10.90M | 10.90M | 11.10M | 11.10M | 10.40M | 10.20M | 9.90M |
| Stock-Based Compensation | 2.20M | 1.60M | 3.10M | 900.00K | 2.20M | 1.90M | 2.10M | 2.20M | 2.10M | 2.10M | 2.10M | 2.00M |
| Change in Working Capital | -42.10M | -25.50M | 19.80M | -6.70M | -3.90M | -27.00M | -14.30M | 21.20M | -32.70M | 13.80M | 29.20M | 6.60M |
| Operating Cash Flow | 7.20M | 17.60M | 61.40M | 38.10M | 10.50M | 28.30M | 25.70M | 73.50M | 4.70M | 80.60M | 72.40M | 58.10M |
| Capital Expenditures | -17.70M | -8.90M | -14.60M | -14.30M | -13.00M | -8.40M | -12.10M | -7.70M | -10.90M | -10.70M | -16.90M | -12.60M |
| Investing Cash Flow | -16.50M | -13.70M | -19.20M | -24.20M | -16.20M | -15.50M | -20.60M | -11.70M | -15.40M | -14.30M | -55.80M | -16.70M |
| Dividends Paid | — | — | -21.60M | 0 | — | — | -19.80M | 0 | — | — | -17.90M | 0 |
| Share Repurchases | -6.40M | -7.10M | 0 | -10.60M | -8.50M | -4.80M | 0 | 0 | -300.00K | -400.00K | -100.00K | 0 |
| Financing Cash Flow | -29.50M | -6.60M | -20.60M | -9.60M | -29.90M | -3.80M | -17.80M | 900.00K | -18.90M | 500.00K | -20.40M | 200.00K |
| Net Change in Cash | -38.90M | -3.40M | 21.70M | 4.20M | -33.20M | 10.60M | -14.60M | 63.60M | -29.90M | 66.40M | -3.50M | 41.30M |
| Free Cash Flow | -10.50M | 8.70M | 46.80M | 23.80M | -2.50M | 19.90M | 13.60M | 65.80M | -6.20M | 69.90M | 55.50M | 45.50M |
This table shows 12 quarterly periods of Innospec's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IOSP's reporting calendar. What is a cash flow statement?